Baby Safety / Compounds / Deferasirox (Exjade / Jadenu / ICL670 / oral iron chelator)

Is Deferasirox (Exjade / Jadenu / ICL670 / oral iron chelator) safe for babies and kids?

Very high risk for kids

Infants are more vulnerable to Deferasirox (Exjade / Jadenu / ICL670 / oral iron chelator) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is deferasirox (exjade / jadenu / icl670 / oral iron chelator)?

The IUPAC name is 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid.

Also known as: Deferasirox, 201530-41-8, Exjade, ICL 670.

IUPAC name
4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid
CAS number
201530-41-8
Molecular formula
C21H15N3O4
Molecular weight
373.4 g/mol
SMILES
C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O
PubChem CID
214348

Risk for babies

Very high risk

Infants are more vulnerable to Deferasirox (Exjade / Jadenu / ICL670 / oral iron chelator) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Regulatory consensus

3 regulatory and scientific bodies have classified Deferasirox (Exjade / Jadenu / ICL670 / oral iron chelator). The classifications differ — that's the data.

AgencyYearClassificationNotes
FDA—Approved drug (NDA 021882); Black Box Warning for renal/hepatic toxicity and GI hemorrhage
EMA—Approved; conditional — monthly monitoring required
WHO—Essential Medicine — iron overload

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter deferasirox (exjade / jadenu / icl670 / oral iron chelator)

  • Pharmaceutical — oral iron chelation (thalassemia major/intermedia), sickle cell transfusional overload
  • Medical — chronic transfusion patients, hereditary hemochromatosis (off-label)

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Deferasirox (Exjade / Jadenu / ICL670 / oral iron chelator):

  • Deferoxamine
    Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.
  • Deferiprone
    Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.

Frequently asked questions

Is deferasirox (exjade / jadenu / icl670 / oral iron chelator) safe for kids?

Infants are more vulnerable to Deferasirox (Exjade / Jadenu / ICL670 / oral iron chelator) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What products contain deferasirox (exjade / jadenu / icl670 / oral iron chelator)?

Deferasirox (Exjade / Jadenu / ICL670 / oral iron chelator) appears in: oral iron chelation (thalassemia major/intermedia) (pharmaceutical); sickle cell transfusional overload (pharmaceutical); chronic transfusion patients (medical); hereditary hemochromatosis (off-label) (medical).

What should I do if my child is exposed to deferasirox (exjade / jadenu / icl670 / oral iron chelator)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about deferasirox (exjade / jadenu / icl670 / oral iron chelator)?

Deferasirox (Exjade / Jadenu / ICL670 / oral iron chelator) has been classified by 3 agencies including FDA, EMA, WHO, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Deferasirox (Exjade / Jadenu / ICL670 / oral iron chelator) in the baby app

Look up products containing deferasirox (exjade / jadenu / icl670 / oral iron chelator), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. — expert_curation

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →